Carmignac Gestion’s UnitedHealth UNH Stock Holding History

Carmignac Gestion’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Hold	–	-$72.5K	–	166
2025 Q3	–	Hold	–	–	–	126
2025 Q2	–	Hold	–	–	–	129

Other funds holding UNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Carmignac Gestion's UNH Position: Q4 2024 in Review

Carmignac Gestion sold out of UnitedHealth (UNH) in Q4 2024, closing a stake of 358,361 shares — an estimated $210M sold.

Carmignac Gestion first reported a position in UNH in Q4 2020 and held it in 11 quarters. The position peaked at $210M in Q3 2024. 3,674 funds tracked by Wall St. Rank hold UNH as of Q4 2024.

Carmignac Gestion reported no remaining UnitedHealth position as of Q4 2024 after selling out during the quarter.
Carmignac Gestion sold 358,361 UnitedHealth shares in Q4 2024, an estimated $210M.
Carmignac Gestion first reported a position in UnitedHealth in Q4 2020 and held it in 11 quarters.
Carmignac Gestion's UnitedHealth position peaked at $210M in Q3 2024.
3,674 funds tracked by Wall St. Rank held UnitedHealth as of Q4 2024.

Based on Carmignac Gestion's 13F filing for Q4 2024, filed 13 Feb 2025.